beta-hydroxyisovaleric acid has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Absalón-Aguilar, A; Cervantes-Díaz, R; Gómez-Martín, D; Hernández-Gilsoul, T; Juárez-Vega, G; Kleinberg-Bid, A; Llorente, L; Maravillas-Montero, JL; Mejía-Domínguez, NR; Meza-Sánchez, D; Nuñez-Aguirre, M; Páez-Franco, JC; Pérez-Fragoso, A; Ponce-de-León, A; Romero-Ramírez, S; Sosa-Hernández, VA; Torres-Ruiz, J | 1 |
| Alquati, O; Balzarini, A; Caccialanza, R; Cereda, E; Cerri, M; Cozzi, S; Crotti, S; Grasselli, G; Guzzardella, A; Masi, S; Pennacchio, N; Piano, M; Resta, MV; Ripamonti, C; Tamayo, L; Tavola, M; Vadalà, R | 1 |
2 other study(ies) available for beta-hydroxyisovaleric acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.
Topics: Adult; Blood Coagulation; Body Mass Index; COVID-19; Cytokines; Extracellular Traps; Female; Hemoglobins; Humans; Male; Metabolome; Middle Aged; Muscular Atrophy; Neutrophils; Phenotype; Prognosis; SARS-CoV-2; Serum Albumin, Human; Severity of Illness Index; T-Lymphocytes; Valerates | 2021 |
Potential benefits of using an energy-dense, high-protein formula enriched with β-hydroxy-β-methylbutyrate, fructo-oligosaccharide, and vitamin D for enteral feeding in the ICU: A pilot case-control study in COVID-19 patients.
Topics: Case-Control Studies; COVID-19; Critical Illness; Energy Intake; Enteral Nutrition; Humans; Intensive Care Units; Oligosaccharides; Proteins; Respiration, Artificial; Vitamin D | 2023 |